- Home
- CSIQ vs ORIC Comparison
CSIQ vs ORIC Comparison
Compare CSIQ & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSIQ | ORIC |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | Canada | United States |
| Employees | N/A | 104 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.4M | 861.3M |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CSIQ | ORIC |
|---|---|---|
| Price | $19.09 | $8.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | $17.36 | ★ $19.73 |
| AVG Volume (30 Days) | ★ 3.1M | 1.2M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.61 | N/A |
| Revenue Next Year | $13.90 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.41 | $5.51 |
| 52 Week High | $34.59 | $14.93 |
Technical Indicators
Market Signals| Indicator | CSIQ | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 60.07 | 37.06 |
| Support Level | $12.75 | $7.90 |
| Resistance Level | $20.60 | $11.22 |
| Average True Range (ATR) | 1.53 | 0.44 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 68.50 | 30.75 |
Price Performance
Historical ComparisonAbout CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.